These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Validation of Persian Version of Mindful Attention Awareness Scale (MAAS) in Iranian Women with Breast Cancer.
    Author: Nooripour R, Ghanbari N, Hassani-Abharian P, Radwin LE, Hosseinian S, Hasanvandi S.
    Journal: Arch Iran Med; 2022 May 01; 25(5):300-307. PubMed ID: 35943005.
    Abstract:
    BACKGROUND: Breast cancer is now the most significant health issue in women, threatening diverse aspects of human health, including mental health and cognitive function. This research aimed to validate the Persian version of Mindful Attention Awareness Scale (MAAS) in Iranian women with breast cancer. METHODS: We gathered data on 229 women with breast cancer in Tehran through convenience sampling. They completed a demographic questionnaire, the Persian version of MAAS, the General Self-Efficacy Scale, and DASS-21. SPSS-22 analyzed the Pearson correlation between the Persian version of MAAS, general self-efficacy, and DASS-21. Also, LISREL 8.8 was used to analyze the internal structure of the MAAS. RESULTS: Findings from the confirmatory factor analysis (CFA) showed that the model with one factor fits well with the data (sbχ2=4.29 (P=0.36); SRMR=0.058; CFI=1.0; NFI=0.91; IFI=0.95; RFI=0.97; GFI=0.90; RMSEA=0.069). Significant negative correlations were found between MAAS and DASS-21 scores for anxiety (r=-0.51), depression (r=-0.48) and stress (r=-0.49), indicating an acceptable divergent validity. There was also a positive relationship between MAAS and general self-efficacy (r=0.37; P<0.01). CONCLUSION: The Persian version of MAAS seems to be a valid scale for evaluating the extent of mindfulness of Iranian women with breast cancer.
    [Abstract] [Full Text] [Related] [New Search]